Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePulmonx Corporation Common Stock
XNAS•Health Care•Surgical & Medical Instruments & Apparatus
Flagged at $2.37 at 09:29 AM on Oct 28, then ran to $2.77 +17% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is LUNG up today? It is at $2.59 (+30.81%), and our scanner flagged it 61 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LUNG spikes, and full due diligence on LUNG — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $LUNG 61 times in the last 30 days. Create a free account to track $LUNG, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
LUNG is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 19 unusual-volume and momentum alerts on LUNG today, peaking at 114.0x its normal volume. Fresh from the SEC: Pulmonx Corp: Pulmonx Reports Third Quarter 2026 Financial Results. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystPulmonx Reports Third Quarter 2026 Financial ResultsReported Achieved worldwide revenue of $22.8 million in the third quarter of 2026, a 6% increase over the same period last year on both a GAAP and constant currency basisReported Delivered $14.9 million in U.S. revenue in the third quarter of 2026, representing a 7% year-over-year increaseReported Realized gross margin of 76% in the third quarter of 2026, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Rose Geoffrey Beran Officer | Sold (automatic/other) | -8K 0.02% of company | sold 1.7% | 450K | $18K at $2.26 | Sep 1, 26 |
Lehman David Aaron Officer | Sold (automatic/other) | -14K 0.03% of company | sold 3.8% | 362K | $32K at $2.26 | Sep 1, 26 |
Radhakrishnan Srikanth Officer | Sold (automatic/other) | -14K 0.03% of company | sold 4.3% | 317K | $32K at $2.26 | Sep 1, 26 |
French Glendon E. Iii Officer | Sold (automatic/other) | -42K 0.10% of company | sold 3.5% | 1.14M | $95K at $2.26 | Sep 1, 26 |
Mead Dana G Jr. Director | Acquired (grant/award) | +40K 0.09% of company | added 40% | 140K | n/a | Jun 5, 26 |
Sullivan Tiffany Director | Acquired (grant/award) | +40K 0.09% of company | added 53% | 115K | n/a | Jun 5, 26 |
Melenikiotou Georgia Director | Acquired (grant/award) | +40K 0.09% of company | added 40% | 140K | n/a | Jun 5, 26 |
Florin Daniel P Director | Acquired (grant/award) | +40K 0.09% of company | added 43% | 134K | n/a | Jun 5, 26 |
Ferrari Richard Director | Acquired (grant/award) | +40K 0.09% of company | added 46% | 127K | n/a | Jun 5, 26 |
Burns Thomas William Director | Acquired (grant/award) | +40K 0.09% of company | added 54% | 113K | n/a | Jun 5, 26 |
French Glendon E. Iii Officer | Sold (automatic/other) | -14K 0.03% of company | sold 1.1% | 1.18M | $21K at $1.57 | Jun 2, 26 |
French Glendon E. Iii Officer | Sold (automatic/other) | -43K 0.10% of company | sold 3.5% | 1.19M | $66K at $1.54 | Jun 1, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in surgical & medical instruments & apparatus, closest in size first.
LUNG is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 19 unusual-volume and momentum alerts on LUNG today, peaking at 114.0x its normal volume. Fresh from the SEC: Pulmonx Corp: Pulmonx Reports Third Quarter 2026 Financial Results. A material company disclosure like this is often the real catalyst behind a move of this size.
LUNG last traded at $2.59, up 30.81% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The LUNG Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LUNG 61 times in the last 30 days.
LUNG (Pulmonx Corporation Common Stock) trades on XNAS, with a market cap of about $85M in the Surgical & Medical Instruments & Apparatus sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LUNG for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$LUNG discussion
Sign in to ask a question or join the discussion.